SSI Strategy Acquires Fiore Healthcare Advisors
June 29, 2021
SSI Strategy, a life sciences consultancy backed by Amulet Capital Partners, has acquired Fiore Healthcare Advisors, a Boston-based pharmacovigilance and clinical research consultancy. The acquisition adds Safety Physicians and clinical research experts to SSI, expanding the company's drug safety, pharmacovigilance and clinical research capabilities for early- and mid-stage biopharma clients.
- Buyers
- SSI Strategy, LLC
- Targets
- Fiore Healthcare Advisors, LLC
- Industry
- Healthcare Services
- Location
- Massachusetts, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Clinigen Acquires SSI Strategy
November 21, 2025
Healthcare Services
Clinigen has completed the acquisition of SSI Strategy, adding SSI's strategic advisory capabilities and an established U.S. and European footprint to Clinigen's global pharmaceutical services platform. The deal brings over 200 employees (including ~145 consultants) and a deep biotech client base to Clinigen, expanding its end-to-end lifecycle services from clinical strategy through global commercialisation.
-
SSI Strategy Acquires NDA Group AB
August 15, 2023
Healthcare Services
SSI Strategy has entered into a definitive agreement to acquire NDA Group AB, a regulatory affairs and drug development consultancy, to create an integrated life sciences consultancy offering end-to-end drug development and regulatory services. The combination, supported by SSI's private equity partner Amulet Capital Partners, expands SSI's regulatory capabilities and geographic footprint across the U.S. and Europe.
-
Amulet Capital Partners Makes Growth Investment in SSI Strategy
December 21, 2020
Healthcare Services
Amulet Capital Partners (a healthcare-focused private equity firm) made a growth equity investment in SSI Strategy Holdings LLC, a Parsippany, New Jersey-based life sciences consulting firm, to accelerate the company’s growth and expand strategic services including a new Gene Therapy Accelerator. The capital will fund team expansion, adjacent service lines and potential tuck-in acquisitions; Simon Kennedy joined SSI Strategy's board in conjunction with the investment.
-
Chartis Acquires HealthScape Advisors
February 6, 2024
Healthcare Services
Chartis, a leading healthcare advisory firm, has acquired HealthScape Advisors, a Chicago-based healthcare payer consulting firm with approximately 160 professionals. The deal expands Chartis' capabilities in the payer segment and strengthens its ability to advise payers and providers on transformational change across commercial, Medicare, Medicaid and federal markets.
-
Remote Medical International Acquires SSI Group
July 1, 2020
Healthcare Services
Remote Medical International completed its acquisition of United Kingdom–based SSI Group on July 1. The deal expands Remote Medical's presence in the renewable energy sector and adds SSI's emergency response, global risk management and international safety capabilities to Remote Medical's workplace health and safety services; company leadership roles for SSI executives were retained and integrated into Remote Medical's global organization. Terms were not disclosed.
-
SAI MedPartners Acquires PharmaForce International
March 29, 2023
Healthcare Services
SAI MedPartners, a consultancy focused on strategic insights and analytics for the pharmaceutical, biotech, and medical device industries, has acquired PharmaForce International, a Reading, Pennsylvania–based market intelligence and syndicated research firm. The acquisition adds PharmaForce's commercial benchmarking and syndicated research capabilities to SAI's competitive intelligence offerings; SAI is PE-backed by Northlane Capital Partners (which partnered with management to acquire SAI in June 2022).
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.